Commentary on the Supplement American Journal of Obstetrics and Gynecology: A Hormonal Contraceptive Update: A Decade of Innovation and Transformation

Journal of Sexual Medicine

Volumn 9, Issue 8, 2012, Pages 2196-2197

  Krychman, Michael ^a   Kellogg Spadt, Susan ^b,c   Burrows, Lara J ^d   Johnson Agbakwu, Crista ^e,f   Goldstein, Irwin ^g   Goldstein, Andrew ^h  

^a Southern California Center for Sexual Health and Survivorship Medicine   (United States)

^b Pelvic and Sexual Health Institute   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^f Maricopa Integrated Health System   (United States)

^g ALVARADO HOSPITAL   (United States)

^h The Centers for Vulvovaginal Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINED ORAL CONTRACEPTIVE; CONTRACEPTIVE AGENT; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ACNE; CANCER PREVENTION; CONTRACEPTION; DYSMENORRHEA; HUMAN; LETTER; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SOCIETY; PREGNANCY; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SEXUALITY;

EID: 84864498559     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02797.x     Document Type: Letter

References (6)

1. Panzer C, Wise S, Fantini G, Kang D, Munarriz R, Guay A, Goldstein I. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: A retrospective study in women with sexual dysfunction. J Sex Med 2006;3:104-13.
2. The role of testosterone therapy in postmenopausal women: Position statement of The North American Menopause Society. Menopause 2005;12:496-511; quiz 649. The North American Menopause Society (NAMS) developed this manuscript with assistance from an Editorial Board composed of Jan L. Shifren, MD (Chair); Susan R. Davis, MBBS, FRACP, PhD; Lorraine Dennerstein, AO, MBBS, DPM, PhD, FRANZCP; Julia R. Heiman, PhD, Rogerio A. Lobo, MD; and James A. Simon, MD.
3. ACOG, American College of Obstetricians and Gynecologists (ACOG). Female sexual dysfunction. Washington, DC: American College of Obstetricians and Gynecologists (ACOG); 2011 Apr. 12 p. (ACOG practice bulletin; no. 119).
4. Goldstein A, Burrows L, Goldstein I. Can oral contraceptives cause vestibulodynia? J Sex Med 2010;7(4 Pt 1):1585-7.
5. Greenstein A, Greenstein A, Ben-Aroya Z, Fass O, Militscher I, Roslik Y, Chen J, Abramov L. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med 2007;4:1679-83.
6. Berglund AL, Nigaard L, Rylander E. Vulvar pain, sexual behavior and genital infections in a young population: A pilot study. Acta Obstet Gynecol Scand 2002;81:738-42.